,,iv  #aag? ,,congress  #a/ ,session    
,h4 ,,res4 #bij  ,,9 ,,! ,,h\se ,,(     
,,repres5tatives  ,april #a1 #bjba,mr4  
,s*iff 7= himself1 ,mrs4 ,c>olyn ,b4    
,maloney ( ,new ,york1 ,ms4 ,lee (      
,cali=nia1 ,mr4 ,quigley1 ,mr4 ,rask91  
,ms4 ,cl>k ( ,massa*usetts1 ,ms4        
,ocasio-,cortez1 ,mr4 ,pappas1 & ,mr4   
,torres ( ,new ,york7 submitt$ ! foll[+ 
resolution2 :i* 0 ref]r$ to ! ,committee
 on ,en]gy & ,comm]ce  ,,resolution     
,express+ ! s5se ( ! ,h\se (            
,repres5tatives t blood donation        
policies 9 ! ,unit$ ,/ates %\ld be      
equitable & bas$ on sci5ce4  ,:]eas1 9  
#aihc1 ! ,food & ,drug ,adm9i/ration    
7,,fda71 an ag5cy ( ! ,dep>tm5t ( ,heal?
 & ,human ,s]vices 7,,hhs71 prohibit$ ! 
donation ( blood by any man :o has _h   
sex ) ano!r man 7,,msm7 at any "t s9ce  
#aigg2 ,:]eas1 9 ,decemb] #bjae1 bas$ on
 recomm5dations f ! ,,hhs ,advisory     
,committee on ,blood & ,tissue ,safety &
 ,availability1 ! ,,fda promulgat$      
revis$ regulations to all[ an ,,msm to  

donate blood only if he has n be5       
sexually active = ! pa/ #ab mon?s2      
,:]eas1 on ,april #b1 #bjbj1 ! ,,fda    
issu$ guidance = imm$iate implem5tation 
to address ! urg5t & imm$iate ne$ =     
blood & blood compon5ts2 ,:]eas ! ,,fda 
has *ang$ ! recomm5d$ def]ral p]iod =   
,,msm donors f #ab mon?s to #c mon?s2   
,:]eas a #c-mon? def]ral policy = gay & 
bisexual m5 to donate blood rema9s ov]ly
 /r+5t giv5 ! sci5tific evid5ce1 advanc$
 te/+ me?ods1 & ! safety & quality      
control measures 9 place )9 ! diff]5t   
,,fda-qualifi$ blood donat+ c5t]s2      
,:]eas despite ! modifications made 9   
#bjbj1 a d\ble /&>d rema9s1 z ! revis$  
policy cont9ues to treat gay & bisexual 
m5 diff]5tly f o!rs2 ,:]eas gay &       
bisexual m5 ( color exp]i5ce int]sect+1 
comp\nd$ discrim9ation 9 heal? c>e      
sett+s across ! ,unit$ ,/ates2 ,:]eas ! 
,williams ,in/itute ( ! ,univ]sity (    
,cali=nia at ,los ,angeles ,s*ool ( ,law
 e/imates t1 bas$ on ! population (     
eligible & likely donors among ! ,,msm  

community1 lift+ ! ,f$]al lifetime      
def]ral policy on blood donation by an  
,,msm c\ld result 9 z _m z #d1bjj1jjj   
newly eligible male donors1 ( :i*       
#cfj1fjj w\ld likely donate & g5]ate    
#fae1cjj additional p9ts ( blood2 ,:]eas
 ! increas$ uptake ( pre-exposure       
prophylaxis 7,pr,e,p71 :i* r$uces !     
likelihood t an ,,hiv-negative          
individual w acquire ,,hiv1 has all[$ _m
 m gay & bisexual m5 to be aw>e ( _!    
,,hiv-negative /atus & take /eps to     
effectively elim9ate _! p]sonal risk (  
,,hiv transmission2 ,:]eas ! ,,covid-#ai
 p&emic has result$ 9 ! cancellation (  
?\s&s ( blood drives across ! ,unit$    
,/ates1 r$uc$ ! rate ( blood donations1 
& pos$ long-t]m ?reats to ! ,nation's   
blood supply2 ,:]eas ! ,am]ican ,m$ical 
,association has /at$ t ! e?ical ideal =
 public policy 9 ?is area %\ld be to    
transition away f policy t def]s        
categories ( p]sons bas$ on attribut+ to
 all memb]s risks associat$ ) a         
population & t[>d policy t def]s        

individual donors on gr\nds (           
evid5ce-bas$ risk assessm5t2 & ,:]eas ! 
,,fda is 9 ! process ( aga9 reevaluat+ &
 consid]+ updat+ its blood donor def]ral
 policies z new sci5tific in=mation     
becomes available1 includ+ ! feasibility
 ( mov+ f ! exi/+ id5tity-bas$ def]rals 
relat$ to gr\p risk behaviors to        
alt]nate def]ral options1 su* z ! use ( 
individual risk assessm5ts3 ,n[1 !re=e1 
be x ,t x is ! s5se ( ! ,h\se (         
,repres5tatives t policies gov]n+ blood 
& blood product donation 9 ! ,unit$     
,/ates %\ld-- 7#a7 be gr\nd$ 9 sci5ce2  
7#b7 m9imize def]ral p]iods2  7#c7 be   
bas$ on individual risk factors2  7#d7 n
 unfairly s+le out any gr\p (           
individuals2 &  7#e7 all[ donations by  
all ^? :o c safely d s4